India's Richest People 2026 edition · 1 director · Source: Hurun India
- #1,028 M Sivakumaran ₹2,600 Cr
Revenue · FY 2025
₹9.49 Cr
▲ 3082% YoY
Net loss · FY 2025
₹812.07 Cr
Latest filing
EBITDA · FY 2025
-₹623.02 Cr
Latest filing
Authorised capital
₹115 Cr
Registered with MCA
Paid-up capital
₹102.06 Cr
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
424
Provident fund records
Directors on board
3
As per MCA filings
About Curateq Biologics Private Limited
Data last updated:
Curateq Biologics Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Aurobindo Pharma Ltd. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 25 April 2020 and has been in existence for over 6 years.
Its director M Sivakumaran is #1,028 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG2020PTC140190. Its GSTIN is 36AAICC7056M1Z6 (Telangana).
The company has an authorised share capital of ₹115 Cr and a paid-up capital of ₹102.06 Cr. It is led by directors including Madan Mohan Reddy Mettu and Sivakumaran Meenakshisunderam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Galaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.49 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹812.07 Cr and EBITDA of -₹623.02 Cr. Revenue has grown at a compounded annual rate (CAGR) of 78% over three years.
The company has about 424 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 2 brands: CuraTeQ Biologics and Aurobindo Pharma. The company has 4 deals on record (3 convertible or debt financings, 1 rights issue), with disclosed funding of ₹1,620 Cr; the latest was in April 2022. The company has 8 MSME Form 1 returns on record between 2020 and 2024, listing 49 overdue payments to 24 micro and small suppliers.
For more details, the company can be reached via its website curateqbio.com.
Company details
CIN U24110TG2020PTC140190
Registration Number 140190
Incorporation Date 25 April 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Aurobindo Pharma Ltd
Key People
Madan Mohan Reddy Mettu Director Sivakumaran Meenakshisunderam Director Mylandlahalli Rammohan Ashwini Director Recognitions & Rankings of Curateq Biologics
Contact details
Curateq Biologics Private Limited's registered office is in Hyderabad, Telangana. Its website is curateqbio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressGalaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032
- IndustryLife Sciences, Biotechnology
To see the full contact details of Curateq Biologics Private Limited, buy the company report.
Comprehensive company report
Curateq Biologics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Curateq Biologics operates two associated brands: CuraTeQ Biologics and Aurobindo Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops high-quality biosimilars for oncology and immunology to enhance patient access worldwide. | curateqbio.com | |
| Generic biocatalytic solutions are provided for pharmaceutical applications. | aurobindo.com |
Business activity
The main business activity of Curateq Biologics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Curateq Biologics Private Limited, buy the company report.
Financials of Curateq Biologics Private Limited
FY 2025 filings availableCurateq Biologics Private Limited reported revenue of ₹9.49 Cr (up 3082% YoY) for FY 2025.
Revenue · FY 2025
₹9.49 Cr ▲ 3082%
Net loss · FY 2025
₹812.07 Cr
EBITDA · FY 2025
-₹623.02 Cr
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 78%
EBITDA CAGR growth
1 year
▼ 15%
3 years · compounded
▼ 35%
Revenue has grown at a compounded annual rate (CAGR) of 78% over three years. EBITDA fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹623.02 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹812.07 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Curateq Biologics Private Limited, buy the company report.
Board of directors of Curateq Biologics Private Limited
Curateq Biologics has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madan Mohan Reddy Mettu Also directs: MSS Packaging Industries LLP, Aurobindo Pharma Ltd, Engenra Biologics Private Limited and 5 more | Director | 25 Apr 2020 | 6 Years 6 Months | Current |
| Sivakumaran Meenakshisunderam Also directs: Eugia Steriles Private Limited, Tergene Biotech Limited, Auro Peptides Limited and 2 more | Director | 25 Apr 2020 | 6 Years 6 Months | Current |
| Mylandlahalli Rammohan Ashwini Also directs: Auro Vaccines Private Limited, Eugia Sez Private Limited, Auro Peptides Limited and 3 more | Director | 17 May 2024 | 2 Years 5 Months | Current |
Auditor
Curateq Biologics Private Limited is audited by G P M & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G P M & ASSOCIATES | FY 2023 | 015343S |
Shareholding
The shareholding of Curateq Biologics Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Curateq Biologics Private Limited, buy the company report.
Deals & funding
Curateq Biologics Private Limited has 4 deals on record (3 convertible or debt financings, 1 rights issue), with disclosed funding of ₹1,620 Cr; the latest was in April 2022.
Total deals
4
Convertible or debt financings
3
Rights issue
1
Disclosed funding
₹1,620 Cr
Deals on record (1 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2020 | Rights issue | ₹99.9 Cr | Investors: Aurobindo Pharma Ltd |
To see the full deal history of Curateq Biologics Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Curateq Biologics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Curateq Biologics Private Limited has 8 MSME Form 1 returns on record between 2020 and 2024, listing 49 overdue payments to 24 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 24)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Hiten Techno Products Corporation | |||
| an individual supplier | |||
| Vinair Systems Private Limited | |||
| Sri Balaji Gases & Chemicals | |||
| Wheecon Instruments Private Limited |
To see the full MSME payment records of Curateq Biologics Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Curateq Biologics has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Theranym Biologics Private Limited | U24230TG2022PTC166946 |
To see the full group structure of Curateq Biologics Private Limited, buy the company report.
Employees & EPFO
Curateq Biologics Private Limited has a workforce of 424 employees on its EPFO records as of Aug 06, 2024, across 1 active EPFO establishment.
Employee count
424
Active EPFO establishments
1
Employee growth
13.67%
GST
Curateq Biologics has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICC7056M1Z6 | Telangana | Active | 30 Apr 2020 |
To see the full GST registrations and return filing status of Curateq Biologics Private Limited, buy the company report.
Recent activity
Curateq Biologics Private Limited has 8 board changes on record since 2020: 4 appointments and 4 cessations. The latest: Mylandlahalli Rammohan Ashwini ceased to be Additional Director on 18 Aug 2024.
AGM
Curateq Biologics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Curateq Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Mylandlahalli Rammohan Ashwini ceased to be Additional Director.
Appointed
Mylandlahalli Rammohan Ashwini was appointed as Director.
Ceased
Sarath Chandra Reddy Penaka ceased to be Director.
Ceased
Sapna ceased to be Additional Director.
Appointed
Satakarni Makkapati was appointed as CEO.
Ceased
Nityananda Reddy Kambam ceased to be Additional Director.
Appointed
Madan Mohan Reddy Mettu was appointed as Director.
Appointed
Sivakumaran Meenakshisunderam was appointed as Director.
Incorporation
25 Apr 2020
Curateq Biologics Private Limited was registered on 25 Apr 2020 with Roc Hyderabad & aged 6 years 6 months as per MCA records.
News
Frequently asked questions
Curateq Biologics is an active private limited company based in Hyderabad, Telangana, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 25 April 2020 (6+ years old) and is registered under CIN U24110TG2020PTC140190.
Curateq Biologics has 3 current directors:
- Madan Mohan Reddy Mettu - Director
- Sivakumaran Meenakshisunderam - Director
- Mylandlahalli Rammohan Ashwini - Director
The latest financial statements of Curateq Biologics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Curateq Biologics is 36AAICC7056M1Z6, registered in Telangana.
The CIN (Corporate Identification Number) of Curateq Biologics is U24110TG2020PTC140190. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curateq Biologics was incorporated on 25 April 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Curateq Biologics has 4 deals on record (3 convertible or debt financings, 1 rights issue), with disclosed funding of ₹1,620 Cr; the latest was in April 2022.
Mylandlahalli Rammohan Ashwini ceased to be Additional Director on 18 Aug 2024. Mylandlahalli Rammohan Ashwini was appointed as Director on 17 May 2024. Sarath Chandra Reddy Penaka ceased to be Director on 01 Mar 2022. Curateq Biologics has 8 board changes on record in total.
Curateq Biologics has 8 MSME Form 1 returns on record between 2020 and 2024, listing 49 overdue payments to 24 micro and small suppliers. The latest return was filed on 29 Apr 2024.
Curateq Biologics can be reached through the website curateqbio.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Curateq Biologics is at Galaxy Floors 22 – 24 Plot No. 1 Survey No. 831 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages